Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Bouloukaki, Izolde ^a   Tsiligianni, Ioanna G ^a   Tsoumakidou, Maria ^a,b   Mitrouska, Ioanna ^a   Prokopakis, Emmanuel P ^a   Mavroudi, Irene ^a   Siafakas, Nikolaos M ^a   Tzanakis, Nikolaos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CLARA CELL PROTEIN; ELAFIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; BETA DEFENSIN; BIOLOGICAL MARKER; CLARA CELL SECRETORY PROTEIN; DEFB4A PROTEIN, HUMAN; UTEROGLOBIN;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASAL LAVAGE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOKING CESSATION; SPUTUM ANALYSIS; CASE CONTROL STUDY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NOSE MUCUS; SMOKING; SPUTUM; TIME;

ADULT; BETA-DEFENSINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ELAFIN; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SMOKING; SMOKING CESSATION; SPUTUM; TIME FACTORS; UTEROGLOBIN;

EID: 79957869358     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-35     Document Type: Article

References (38)

1. Sethi JM, Rochester CL. Smoking and Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 2000, 21:67-86. 10.1016/S0272-5231(05)70008-3, 10763090.
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society. Am J Respir Crit Care Med 1995, 152(suppl):77-121.
3. Weldon S, McGarry N, Taggart CC, McElvaney NG. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem Soc Trans 2007, 35(Pt 2):273-276.
4. Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clin Sci (Lond) 2006, 110:21-35.
5. Bernard A, Roels H, Buchet JP, Lauwerys R. Decrease of serum Clara cell protein in smokers. Lancet 1992, 339(8809):1620.
6. Lindahl M, Svartz J, Tagesson C. Demonstration of different forms of the anti-inflammatory proteins lipocortin-1 and Clara cell protein-16 in human nasal and bronchoalveolar lavage fluids. Electrophoresis 1999, 20:881-890. 10.1002/(SICI)1522-2683(19990101)20:4/5<881::AID-ELPS881>3.0.CO;2-6, 10344263.
7. Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy 2000, 3:469-475.
8. McCray PB, Bentley L. Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol 1997, 16:343-349.
9. Tecle T, Tripathi S, Hartshorn KL. Review: Defensins and cathelicidins in lung immunity. Innate Immunity 2010, 16:151-159. 10.1177/1753425910365734, 20418263.
10. Lund J, Anderson O, Ripe E. Characterization of a binding protein for the PCB metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl present in bronchoalveolar lavage from healthy smokers and non-smokers. Toxicol Appl Pharmacol 1986, 83:486-493. 10.1016/0041-008X(86)90231-0, 3085288.
11. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992, 5:1231-1238.
12. Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997, 10:1108-1114. 10.1183/09031936.97.10051108, 9163654.
13. Shijubo N, Honda Y, Itoh Y, Yamaguchi T, Kuroki Y, Akino T, Kawai T, Abe S. BAL surfactant protein A and Clara cell 10-kDa protein levels in healthy subjects. Lung 1998, 176:257-265. 10.1007/PL00007608, 9617742.
14. Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, De Paepe K, Vaerman JP, Decramer M, Sibille Y. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:185-194.
15. Robin M, Dong P, Hermans C, Bernard A, Bersten AD, Doyle IR. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002, 20:1152-1161. 10.1183/09031936.02.02042001, 12449168.
16. Bernard AM, Roels HA, Buchet JP, Lauwerys RR. Serum Clara cell protein: an indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res 1994, 66:96-104. 10.1006/enrs.1994.1047, 8013441.
17. Bernard AM, Gonzalez-Lorenzo JM, Siles E, Trujillano G, Lauwerys R. Early decrease of serum Clara cell protein in silica-exposed workers. Eur Respir J 1994, 7:1932-1937.
18. Ghafouri B, Ståhlbom B, Tagesson C, Lindahl M. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2002, 2:112-120. 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N, 11788998.
19. Braido F, Riccio AM, Guerra L, Gamalero C, Zolezzi A, Tarantini F, De Giovanni B, Folli C, Descalzi D, Canonica GW. Clara cell 16 protein in COPD sputum: a marker of small airways damage?. Respir Med 2007, 101:2119-2124. 10.1016/j.rmed.2007.05.023, 17624750.
20. Tsoumakidou M, Bouloukaki I, Thimaki K, Tzanakis N, Siafakas NM. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Exp Lung Res 2010, 36:373-380. 10.3109/01902141003690389, 20653472.
21. Ekberg-Jansson A, Andersson B, Bake B, Boijsen M, Enanden I, Rosengren A, Skoogh BE, Tylén U, Venge P, Löfdahl CG. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001, 95:363-373. 10.1053/rmed.2001.1050, 11392577.
22. Cavarra E, Lucattelli M, Gambelli F, Bartalesi B, Fineschi S, Szarka A, Giannerini F, Martorana PA, Lungarella G. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. Am J Physiol Lung Cell Mol Physiol 2001, 281:L412-417.
23. Shibata Y, Abe S, Inoue S, Takabatake N, Igarashi A, Takeishi Y, Sata M, Kubota I. Altered expression of antimicrobial molecules in cigarette smoke-exposed emphysematous mice lungs. Respirology 2008, 13:1061-1065.
24. Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, Welte T, Schroeder JM, Vogelmeier C, . R Bals for the CAPNETZ Study Group Suppression of pulmonary innate host defence in smokers. Thorax 2009, 64:144-149. 10.1136/thx.2008.102681, 18852155, R Bals for the CAPNETZ Study Group.
25. Aarbiou J, Rabe KF, Hiemstra PS. Role of defensins in inflammatory lung disease. Ann Med 2002, 34:96-101. 10.1080/07853890252953482, 12108580.
26. Andersson O, Cassel TN, Sköld CM, Eklund A, Lund J, Nord M. Clara cell secretory protein. Levels in BAL fluid after smoking cessation. Chest 2000, 118:180-182. 10.1378/chest.118.1.180, 10893376.
27. Persson CG, Svensson C, Greiff L, Anderson M, Wollmer P, Alkner U, Erjefält I. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992, 47:993-1000. 10.1136/thx.47.12.993, 1021088, 1494783.
28. Montuschi P, Macagno F, Parente P, Valente S, Lauriola L, Ciappi G, Kharitonov SA, Barnes PJ, Ciabattoni G. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 2005, 60:827-33. 10.1136/thx.2004.035592, 1747215, 16192367.
29. Lipworth BJ, White PS. Allergic inflammation in the unified airway: start with the nose. Thorax 2000, 55:878-881. 10.1136/thorax.55.10.878, 1745607, 10992543.
30. Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G, Ciabattoni G. Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate. Inflamm Res 2003, 52:502-7. 10.1007/s00011-003-1212-6, 14991078.
31. Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G, Barnes PJ, Ciabattoni G. Validation of leukotriene B4 measurements in exhaled breath condensate. Inflamm Res 2003, 52:69-73. 10.1007/s000110300003, 12665124.
32. Montuschi P. Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007, 1:5-23. 10.1177/1753465807082373, 19124344.
33. Montuschi P, Santonico M, Mondino C, Pennazza G, Mantini G, Martinelli E, Capuano R, Ciabattoni G, Paolesse R, Di Natale C, Barnes PJ, D'Amico A. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest 2010, 137:790-796. 10.1378/chest.09-1836, 20081096.
34. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000, 1:87-92. 10.1186/rr18, 59548, 11667971.
35. Pace E, Ferraro M, Minervini MI, Chiappara G, Montalbano AM, Siena L, Pipitone L, Bonsignore G, Gjomarkaj M. Altered expression of TLR4 and of beta 2 defensin in chronic obstructive pulmonary disease [abstract]. Eur Respir J 2006, 28(Suppl 50):s549-P3167.
36. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007, 8:84. 10.1186/1465-9921-8-84, 2194695, 18034897.
37. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002, 57:667-671. 10.1136/thorax.57.8.667, 1746392, 12149524.
38. de Burbure C, Pignatti P, Corradi M, Malerba M, Clippe A, Dumont X, Moscato G, Mutti A, Bernard A. Uteroglobin-related protein 1 and clara cell protein in induced sputum of patients with asthma and rhinitis. Chest 2007, 131:172-179. 10.1378/chest.06-0835, 17218572.